Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01372683 · ClinicalTrials.gov registry record · Phase 4

Oat Breakfast Satiety Study

A Phase 4 study, sponsored by PepsiCo Global R&D.

Completed
Registry status
Phase 4
Development phase
96
Enrollment target

NCT01372683: Completed Phase 4 study, sponsored by PepsiCo Global R&D.

NCT01372683 is a Phase 4 study that has completed, run by PepsiCo Global R&D. The registered enrollment target is 96 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01372683, a Phase 4 study, has completed, sponsored by PepsiCo Global R&D.

COMPLETED
Registry status
Phase 4
Development phase
96 participants
Enrollment target

Study Summary

This study is designed to test the hypothesis that on an equivalent calorie basis, oat based breakfast cereals do not provide the same satiety benefit. The study will also demonstrate the satiety comparison of the cereals related to product density.

Interventions

  • OTHER Dietary Intervention

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2011-05
Est. Completion 2011-12
Phase Phase 4
PepsiCo Global R&D

47 total trials

What the finished NCT01372683 record still lists

NCT01372683 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which Dietary Intervention is the first listed.

NCT01372683 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01372683 about?

NCT01372683 is a clinical study titled "Oat Breakfast Satiety Study". This study is designed to test the hypothesis that on an equivalent calorie basis, oat based breakfast cereals do not provide the same satiety benefit. The study will also demonstrate the satiety comparison of the cereals related to product density.

What is the current status of trial NCT01372683?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 96 participants. The study started on 2011-05. Estimated completion is 2011-12.

What interventions are being tested in trial NCT01372683?

The interventions under investigation include: Dietary Intervention (OTHER).

Who is sponsoring clinical trial NCT01372683?

This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01372683's enrollment target sits among peer trials

96 863rd of 2000 higher than 1,132 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03401762 · 96 participants · NA

    Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke

  • NCT03471260 · 96 participants · Phase 1

    Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

  • NCT03549559 · 96 participants · NA

    Imaging Histone Deacetylase in the Heart

  • NCT03841058 · 96 participants · Phase 2

    Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01372683, the US trial registry maintained by the National Library of Medicine. NCT01372683 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.